Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Relypsa Inc., USA
ScientificTracks Abstracts: J Bioremed Biodeg
Bo Chen is a Principal Scientist in Relypsa focusing on microparticles as toxin binders for various diseases. After his PhD in 2006 from New York University School of Engineering, and Post-doctoral studies from University of California San Francisco in 2009, he started his Sanofi-Genzyme career in Biomaterials and Drug Delivery Division. He left as a Senior Scientist in 2014 and joined biotech company CPGJ (Shanghai) as an Associate Director, later in GrayBug Inc. He has broad experience in Antibody Drug Conjugate (ADC) and Drug Delivery. He has published more than 20 papers/patents. He has been serving as a Guest Editor of Current Cancer Drug Targets since 2014.
Email: [email protected]
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals